Therapies for IRDs: Moving Beyond Single-Gene Solutions

Emerging gene-agnostic strategies target shared pathways and offer options for IRD patients without mutation-specific therapies.

Aykut Demirkol, MD; Rajvir Solanky; Jayvin Hernandez-Reyes; Ilay Demirkol; and Kuzey Soydas

Genetic Testing in the Retina Practice

What’s changing and why it matters.

Timothy S. Lee, MD; Eric W. Lai, MD; and Sidney A. Schechet, MD

Rare Disease Mystery Cases

Can you diagnose these unusual cases based on the examination and imaging?

Kenneth C. Fan, MD, MBA; Caroline C. Awh, MD; Nimesh A. Patel, MD; Marta Stevanovic, MD, MSc; Maria Emfietzoglou, MD; Demetrios Vavvas, MD, PhD; Mary V. Lang; Lisa A. Schimmenti, MD; Brittni A. Scruggs, MD, PhD; Yicheng Bao, MD; and Hossein Ameri, MD, PhD, FRCSI, MRCOphth

Highlights From the 2026 Duke fAVS Course

Retina fellows gathered to learn from the experts and gain hands-on wet lab experience.

Emily H. Jung, MD; Naveen Karthik, MD; Haley S. D’Souza, MD, MS; Omar A. Halawa, MD; and Ryan Sameen Meshkin, MD